Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of IDP-102 gel for common warts
2005-002820-32Phase 2Completed
- Sponsor
- Dow Pharmaceutical Sciences
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluorouracil in common wart (3 arms), sponsored by Dow Pharmaceutical Sciences. Primary endpoint: Primary efficacy endpoint. Started Aug 2005; status: completed.
02
Drugs
fluorouracil
03
Conditions
common wart
Beyond the preview
Go deeper on 2005-002820-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002820-32.